Status:
UNKNOWN
Effect of Radioiodine Therapy on Ovarian Reserve in Female Patients With Differentiated Thyroid Cancer
Lead Sponsor:
Assiut University
Conditions:
Ovarian Insufficiency
Radiation Exposure
Eligibility:
FEMALE
15-45 years
Phase:
NA
Brief Summary
Thyroid carcinoma is the most common endocrine malignancy. Surgery is the standard therapeutic approach for patients with differentiated thyroid carcinoma (DTC), followed by radioiodine (RAI) therapy ...
Eligibility Criteria
Inclusion
- Female patient in childbearing period.
- Female patient with differentiated thyroid carcinoma.
- Underwent thyroidectomy.
- Candidate for radioactive iodine therapy.
Exclusion
- • Male patients.
- Postmenopausal female patients.
- Female patients with undifferentiated thyroid carcinoma.
- Pregnant female patients.
- Lactating female patients.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2021
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04396158
Start Date
June 15 2020
End Date
December 15 2021
Last Update
May 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.